According to the latest report by IMARC Group, titled, “Mesenchymal Stem Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" The study provides a detailed analysis of the industry, including the global mesenchymal stem cells market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights:
How big is the mesenchymal stem cells market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.9 Billion |
| Market Forecast in 2028 | US$ 6.16 Billion |
| Growth rate (2023 to 2028) | CAGR of 13.06% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is mesenchymal stem cells?
Mesenchymal stem cells (MSCs) represent a type of adult stem cell that holds great promise in the field of regenerative medicine. They are present in several tissues in the body, such as bone marrow, adipose tissue (fat), umbilical cord blood, and dental pulp. MSCs possess the remarkable ability to differentiate into multiple types of cells, including bone cells, cartilage cells, muscle cells, and fat cells. They release numerous bioactive molecules, such as cytokines, and extracellular vesicles, which have important roles in tissue regeneration and repair. These molecules can stimulate nearby cells to divide and differentiate, promote the formation of new blood vessels, reduce scarring, and aid in tissue remodeling. Owing to their regenerative potential and their ability to modulate the immune system, MSCs are being extensively studied for an extensive range of therapeutic applications across the globe. Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/mesenchymal-stem-cells-market/requestsampleWhat are the growth prospects and trends in the mesenchymal stem cells industry?
The mesenchymal stem cells market is primarily driven by the inflating healthcare expenditure and the growing prevalence of chronic diseases, especially among the geriatric population across countries. Additionally, the rising demand for effective therapies that can address the underlying causes of these health conditions is acting as another significant growth-inducing factor. In line with this, the elevating use of MSCs in promoting tissue repair and regeneration, making them a potential solution for various medical conditions, is also positively influencing the global market. Moreover, the escalating limitations and safety concerns associated with traditional treatment, the continuous improvements in healthcare infrastructure, and the expanding awareness among the population about the potential benefits of MSC-based therapies are expected to bolster the mesenchymal stem cells market in the coming years.What is included in market segmentation?
The report has segmented the market into the following categories: Breakup by Product & Services:- Products
- Cells and Cell Lines
- Kits, Media, and Reagents
- Others
- Services
- Autologous
- Allogeneic
- Bone Marrow
- Cord Blood
- Peripheral Blood
- Fallopian Tube
- Fetal Liver
- Lung
- Adipose Tissues
- Bone and Cartilage Repair
- Cardiovascular Disease
- Inflammatory and Immunological Diseases
- Liver Diseases
- Cancer
- GvHD
- Others
- Disease Modelling
- Drug Development and Discovery
- Stem Cell Banking
- Tissue Engineering
- Toxicology Studies
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:- ATCC
- Axol Bioscience Ltd.
- Cell Applications Inc.
- Celprogen Inc.
- Cyagen Biosciences Inc.
- Lonza Group AG
- Merck KGaA
- PromoCell GmbH
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.